Effect of antibiotic-impregnated shunts on infection rate in adult hydrocephalus: A single institution's experience

Neurosurgery

Volumn 69, Issue 3, 2011, Pages 625-629

  Farber, S Harrison ^a   Parker, Scott L ^a   Adogwa, Owoicho ^b   McGirt, Matthew J ^b   Rigamonti, Daniele ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antibiotic impregnated shunts; Hydrocephalus

Indexed keywords

ANTIBIOTIC AGENT; OXACILLIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BRAIN PSEUDOTUMOR; CATHETER; CEREBROSPINAL FLUID ANALYSIS; COMMUNICATING HYDROCEPHALUS; DRUG EFFECT; EXPERIENCE; FEMALE; HUMAN; HYDROCEPHALUS; IMPLANT; INCIDENCE; INFECTION RATE; INTRACRANIAL PRESSURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SHUNT INFECTION; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL INSTRUMENT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CEREBROSPINAL FLUID SHUNTS; COHORT STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; HYDROCEPHALUS; HYDROCEPHALUS, NORMAL PRESSURE; MALE; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; PSEUDOTUMOR CEREBRI; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL WOUND INFECTION; YOUNG ADULT;

EID: 80051781909     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31821bc435     Document Type: Article

References (33)

1. Choux M, Genitori L, Lang D, Lena G. Shunt implantation: Reducing the incidence of shunt infection. J Neurosurg. 1992;77(6):875-880.
2. Eymann R, Chehab S, Strowitzki M, Steudel WI, Kiefer M. Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters. J Neurosurg Pediatr. 2008;1(6):444-450.
3. McGirt MJ, Woodworth G, Coon AL, Thomas G, Williams MA, Rigamonti D. Diagnosis, treatment, and analysis of long-term outcomes in idiopathic normalpressure hydrocephalus. Neurosurgery. 2005;57(4):699-705; discussion 699-705.
4. McGirt MJ, Woodworth G, Thomas G, Miller N, Williams M, Rigamonti D. Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: Predictors of treatment response and an analysis of long-term outcomes. J Neurosurg. Oct 2004;101(4):627-632.
5. Puca A, Anile C, Maira G, Rossi G. Cerebrospinal fluid shunting for hydrocephalus in the adult: Factors related to shunt revision. Neurosurgery. 1991;29(6):822-826.
6. Parker SL, Attenello FJ, Sciubba DM, et al. Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts. Childs Nerv Syst. 2009;25(1):77-83; discussion 85.
7. Sciubba DM, Noggle JC, Carson BS, Jallo GI. Antibiotic-impregnated shunt catheters for the treatment of infantile hydrocephalus. Pediatr Neurosurg. 2008;44(2):91-96.
8. Sciubba DM, Stuart RM, McGirt MJ, et al. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg. 2005;103(2 suppl):131-136.
9. Aryan HE, Meltzer HS, Park MS, Bennett RL, Jandial R, Levy ML. Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children. Childs Nerv Syst. 2005;21(1):56-61.
10. Bayston R, Lari J. A study of the sources of infection in colonised shunts. Dev Med Child Neurol. 1974;16(6 suppl 32):16-22.
11. Blount JP, Campbell JA, Haines SJ. Complications in ventricular cerebrospinal fluid shunting. Neurosurg Clin N Am. 1993;4(4):633-656.
12. Borgbjerg BM, Gjerris F, Albeck MJ, Borgesen SE. Risk of infection after cerebrospinal fluid shunt: An analysis of 884 first-time shunts. Acta Neurochir (Wien). 1995;136(1-2):1-7.
13. Chapman PH, Borges LF. Shunt infections: Prevention and treatment. Clin Neurosurg. 1985;32:652-664.
14. Odio C, McCracken GH Jr, Nelson JD. CSF shunt infections in pediatrics. A seven-year experience. Am J Dis Child. 1984;138(12):1103-1108.
15. Hayhurst C, Cooke R, Williams D, Kandasamy J, O'Brien DF, Mallucci CL. The impact of antibiotic-impregnated catheters on shunt infection in children and neonates. Childs Nerv Syst. 2008;24(5):557-562.
16. Pattavilakom A, Xenos C, Bradfield O, Danks RA. Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: An Australian prospective study. J Clin Neurosci. 2007;14(6):526-531.
17. Richards HK, Seeley HM, Pickard JD. Efficacy of antibiotic-impregnated shunt catheters in reducing shunt infection: Data from the United Kingdom Shunt Registry. J Neurosurg Pediatr. 2009;4(4):389-393.
18. McGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K, Sexton DJ. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis. 2003;36(7):858-862.
19. Woodworth GF, McGirt MJ, Williams MA, Rigamonti D. Cerebrospinal fluid drainage and dynamics in the diagnosis of normal pressure hydrocephalus. Neurosurgery. 2009;64(5):919-925; discussion 925-926.
20. Steinbok P, Cochrane DD, Kestle JR. The significance of bacteriologically positive ventriculoperitoneal shunt components in the absence of other signs of shunt infection. J Neurosurg. 1996;84(4):617-623.
21. Everett ED, Eickhoff TC, Simon RH. Cerebrospinal fluid shunt infections with anaerobic diphtheroids (Propionibacteriumspecies). J Neurosurg. 1976;44(5):580-584.
22. Gardner P, Leipzig T, Phillips P. Infections of central nervous system shunts. Med Clin North Am. 1985;69(2):297-314.
23. Hampl J, Schierholz J, Jansen B, Aschoff A. In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections. Acta Neurochir (Wien). 1995;133(3-4):147-152.
24. Peters G, Locci R, Pulverer G. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis. 1982;146(4):479-482.
25. Renier D, Lacombe J, Pierre-Kahn A, Sainte-Rose C, Hirsch JF. Factors causing acute shunt infection. Computer analysis of 1174 operations. J Neurosurg. 1984; 61(6):1072-1078.
26. Ritz R, Roser F, Morgalla M, Dietz K, Tatagiba M, Will BE. Do antibioticimpregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients. BMC Infect Dis. 2007;7:38.
27. Wang KW, Chang WN, Shih TY, et al. Infection of cerebrospinal fluid shunts: Causative pathogens, clinical features, and outcomes. Jpn J Infect Dis. 2004;57(2):44-48.
28. Bayston R, Grove N, Siegel J, Lawellin D, Barsham S. Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry. 1989;52(5):605-609.
29. Bayston R, Lambert E. Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheterrelated infection. J Neurosurg. 1997;87(2):247-251.
30. Kestle JR, Hoffman HJ, Soloniuk D, Humphreys RP, Drake JM, Hendrick EB. A concerted effort to prevent shunt infection. Childs Nerv Syst. 1993;9(3):163-165.
31. Ragel BT, Browd SR, Schmidt RH. Surgical shunt infection: Significant reduction when using intraventricular and systemic antibiotic agents. J Neurosurg. 2006; 105(2):242-247.
32. Ziebuhr W, Hennig S, Eckart M, Kranzler H, Batzilla C, Kozitskaya S. Nosocomial infections by Staphylococcus epidermidis: How a commensal bacterium turns into a pathogen. Int J Antimicrob Agents. 2006;28(suppl 1):S14-S20.
33. Schoenfelder SM, Lange C, Eckart M, Hennig S, Kozytska S, Ziebuhr W. Success through diversity-how Staphylococcus epidermidis establishes as a nosocomial pathogen. Int J Med Microbiol. 2010;300(6):380-386.